SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Pascal Demoly, Moises A Calderon, Thomas B Casale, Hans-Jørgen Malling, Ulrich Wahn, “The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”, Clinical and Translational Allergy, 2015, 5, 1

    CrossRef

  2. 2
    Paul C. Potter, Sheila Baker, Bartha Fenemore, Barbara Nurse, Clinical and cytokine responses to house dust mite sublingual immunotherapy, Annals of Allergy, Asthma & Immunology, 2015, 114, 4, 327

    CrossRef

  3. 3
    Kyung Hee Park, Mina Son, Soo-Young Choi, Hey Jung Park, Jae-Hyun Lee, Kyoung Yong Jeong, Joo-Shil Lee, Jung-Won Park, In VitroEvaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents, Allergy, Asthma & Immunology Research, 2015, 7, 2, 124

    CrossRef

  4. 4
    S. Gomez-André, L’immunothérapie allergénique : les méta-analyses, mise au point en 2015, Revue Française d'Allergologie, 2015, 55, 3, 189

    CrossRef

  5. 5
    Harold Nelson, Shannon Cartier, Felicia Allen-Ramey, Simon Lawton, Moises A. Calderon, Network Meta-analysis Shows Commercialized Subcutaneous and Sublingual Grass Products Have Comparable Efficacy, The Journal of Allergy and Clinical Immunology: In Practice, 2015, 3, 2, 256

    CrossRef

  6. 6
    Chet A. Tharpe, Stephen F. Kemp, Pediatric Allergic Rhinitis, Immunology and Allergy Clinics of North America, 2015, 35, 1, 185

    CrossRef

  7. 7
    Giovanni B Pajno, Kari C Nadeau, Giovanni Passalacqua, Lucia Caminiti, Ben Hobson, David C Jay, Stefania Arasi, Fernanda Chiera, Giuseppina Salzano, The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook, Expert Review of Clinical Immunology, 2015, 11, 1, 141

    CrossRef

  8. 8
    Alexandra F Santos, Luis Miguel Borrego, Giuseppina Rotiroti, Glenis Scadding, Graham Roberts, The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice, Clinical and Translational Allergy, 2015, 5, 1

    CrossRef

  9. 9
    Philippe Devillier, Jean-François Dreyfus, Pascal Demoly, Moisés A Calderón, A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis, BMC Medicine, 2014, 12, 1, 71

    CrossRef

  10. 10
    Carmen Vidal, Pablo Rodríguez del Río, Ana Tabar, Carmen Moreno, Allergen Immunotherapy (AIT) in Allergic Rhinitis: Long-Term Efficacy and the Development of Asthma. What Do We Know?, Current Treatment Options in Allergy, 2014, 1, 1, 14

    CrossRef

  11. 11
    Florence Trebuchon, Michèle Lhéritier-Barrand, Marie David, Pascal Demoly, Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens, Clinical and Translational Allergy, 2014, 4, 1, 15

    CrossRef

  12. 12
    Chae-Seo Rhee, Current Specific Immunotherapy for Allergic Rhinitis: Perspectives from Otorhinolaryngologists, Allergy, Asthma & Immunology Research, 2014, 6, 4, 273

    CrossRef

  13. 13
    Robert A. Wood, Alkis Togias, Jeremy Wildfire, Cynthia M. Visness, Elizabeth C. Matsui, Rebecca Gruchalla, Gurjit Hershey, Andrew H. Liu, George T. O'Connor, Jacqueline A. Pongracic, Edward Zoratti, Frederic Little, Mark Granada, Suzanne Kennedy, Stephen R. Durham, Mohamed H. Shamji, William W. Busse, Development of cockroach immunotherapy by the Inner-City Asthma Consortium, Journal of Allergy and Clinical Immunology, 2014, 133, 3, 846

    CrossRef

  14. 14
    Yohalakshmi Chelladurai, Sandra Y. Lin, Effectiveness of subcutaneous versus sublingual immunotherapy for allergic rhinitis, Current Opinion in Otolaryngology & Head and Neck Surgery, 2014, 22, 3, 211

    CrossRef

  15. 15
    L. Wang, J. Yin, R. Fadel, A. Montagut, O. de Beaumont, P. Devillier, House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma, Allergy, 2014, 69, 9
  16. 16
    David C. Jay, Kari C. Nadeau, Immune Mechanisms of Sublingual Immunotherapy, Current Allergy and Asthma Reports, 2014, 14, 11

    CrossRef

  17. 17
    Jean-Pierre Allam, Natalija Novak, Immunological mechanisms of sublingual immunotherapy, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 6, 564

    CrossRef

  18. 18
    Thomas B. Casale, Jeffrey R. Stokes, Immunotherapy: What lies beyond, Journal of Allergy and Clinical Immunology, 2014, 133, 3, 612

    CrossRef

  19. 19
    Jamee Castillo, Vesselin Dimov, Investigational drugs for the treatment of allergic rhinitis, Expert Opinion on Investigational Drugs, 2014, 23, 6, 823

    CrossRef

  20. 20
    Mübeccel Akdis, Cezmi A. Akdis, Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens, Journal of Allergy and Clinical Immunology, 2014, 133, 3, 621

    CrossRef

  21. 21
    Mohamed H. Shamji, Mechanisms of Allergen-Specific Sublingual Immunotherapy and the Use of Biological Markers in Allergic Rhinitis, Current Treatment Options in Allergy, 2014, 1, 1, 1

    CrossRef

  22. 22
    Michelle B. Lierl, New Developments in the Treatment of Pediatric Allergic Rhinitis and Conjunctivitis, Pediatric Annals, 2014, 43, 8, e192

    CrossRef

  23. 23
    Mübeccel Akdis, New treatments for allergen immunotherapy, World Allergy Organization Journal, 2014, 7, 1, 23

    CrossRef

  24. 24
    Marek Jutel, Małgorzata Bartkowiak-Emeryk, Anna Bręborowicz, Ewa Cichocka-Jarosz, Andrzej Emeryk, Radosław Gawlik, Paweł Gonerko, Barbara Rogala, Anna Nowak-Węgrzyn, Samoliński, Podjęzykowa immunoterapia alergenowa – stanowisko Sekcji Immunoterapii Polskiego Towarzystwa Alergologicznego, Alergologia Polska - Polish Journal of Allergology, 2014, 1, 1, 30

    CrossRef

  25. 25
    Peter S. Creticos, Robert E. Esch, Peter Couroux, Deborah Gentile, Pina D'Angelo, Brad Whitlow, Michael Alexander, Terrance C. Coyne, Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis, Journal of Allergy and Clinical Immunology, 2014, 133, 3, 751

    CrossRef

  26. 26
    Giovanni Passalacqua, Recommendations for appropriate sublingual immunotherapy clinical trials, World Allergy Organization Journal, 2014, 7, 1, 21

    CrossRef

  27. 27
    Franco Frati, Erminia Ridolo, Nicola Fuiano, Salvatore Barberi, Ilaria Dell’Albani, Massimo Landi, Luisa Ricciardi, Guglielmo Scala, Cristoforo Incorvaia, Safety of sublingual immunotherapy in children, Expert Opinion on Drug Safety, 2014, 13, 7, 947

    CrossRef

  28. 28
    Désirée ES Larenas Linnemann, Michael S Blaiss, Selection of patients for sublingual versus subcutaneous immunotherapy, Immunotherapy, 2014, 6, 7, 871

    CrossRef

  29. 29
    Kristian Aasbjerg, Vibeke Backer, Steroids vs immunotherapy for allergic rhinitis – out with the old, in with the new, Expert Review of Clinical Immunology, 2014, 10, 2, 171

    CrossRef

  30. 30
    Harold S. Nelson, Subcutaneous Immunotherapy Versus Sublingual Immunotherapy: Which Is More Effective?, The Journal of Allergy and Clinical Immunology: In Practice, 2014, 2, 2, 144

    CrossRef

  31. 31
    Harold S. Nelson, Sublingual Immunotherapy for Aeroallergens: Optimal Patient Dosing, Regimen and Duration, Current Treatment Options in Allergy, 2014, 1, 1, 79

    CrossRef

  32. 32
    Su Young Jung, Sung Wan Kim, Sublingual immunotherapy for allergic rhinitis, Allergy, Asthma & Respiratory Disease, 2014, 2, 2, 91

    CrossRef

  33. 33
    Sandra Y. Lin, Sublingual immunotherapy: current concepts for the U.S. practitioner, International Forum of Allergy & Rhinology, 2014, 4, S2
  34. 34
    Giorgio Canonica, Linda Cox, Ruby Pawankar, Carlos E Baena-Cagnani, Michael Blaiss, Sergio Bonini, Jean Bousquet, Moises Calderón, Enrico Compalati, Stephen R Durham, Roy van Wijk, Désirée Larenas-Linnemann, Harold Nelson, Giovanni Passalacqua, Oliver Pfaar, Nelson Rosário, Dermot Ryan, Lanny Rosenwasser, Peter Schmid-Grendelmeier, Gianenrico Senna, Erkka Valovirta, Hugo Van Bever, Pakit Vichyanond, Ulrich Wahn, Osman Yusuf, Sublingual immunotherapy: World Allergy Organization position paper 2013 update, World Allergy Organization Journal, 2014, 7, 1, 6

    CrossRef

  35. 35
    Sandra Y. Lin, The changing landscape of allergy immunotherapy in the United States, Current Opinion in Otolaryngology & Head and Neck Surgery, 2014, 22, 3, 206

    CrossRef

  36. 36
    Han Zhou, Qi-Lei Tao, Jun-Min Wei, Geng Xu, Lei Cheng, Trends in Specific Immunotherapy for Allergic Rhinitis: A Survey of Chinese ENT Specialists, Allergy, Asthma & Immunology Research, 2014, 6, 4, 296

    CrossRef

  37. 37
    Tobias Weberschock, Ines Schaefer, Hagen Heigel, Eva Valesky, Matthias Augustin, Jochen Schmitt, Use of specific immunotherapy – a survey of 15 164 employed persons in Germany, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2014, 12, 4
  38. 38
    G. Dutau, F. Lavaud, 8e Congrès francophone d’allergologie, 16 au 19 avril 2013 : un fil rouge pédiatrique !, Revue Française d'Allergologie, 2013, 53, 1, 1

    CrossRef

  39. 39
    Tomokazu Matsuoka, Mohamed H Shamji, Stephen R Durham, Allergen Immunotherapy and Tolerance, Allergology International, 2013, 62, 4, 403

    CrossRef

  40. 40
    Aarif O Eifan, Moises A Calderon, Stephen R Durham, Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma, Expert Opinion on Biological Therapy, 2013, 13, 11, 1543

    CrossRef

  41. 41
    Marco Caminati, Annarita Dama, Michele Schiappoli, Gianenrico Senna, Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?, Expert Review of Clinical Immunology, 2013, 9, 10, 937

    CrossRef

  42. 42
    E. Savi, S. Peveri, G. Senna, G. Passalacqua, Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach, Allergy, 2013, 68, 9
  43. 43
    Deborah Gentile, Ashton Bartholow, Erkka Valovirta, Glenis Scadding, David Skoner, Current and Future Directions in Pediatric Allergic Rhinitis, The Journal of Allergy and Clinical Immunology: In Practice, 2013, 1, 3, 214

    CrossRef

  44. 44
    Gregory Robert Dion, Erik K. Weitzel, Kevin C. McMains, Current Approaches to Diagnosis and Management of Rhinitis, Southern Medical Journal, 2013, 106, 9, 526

    CrossRef

  45. 45
    Sandra Y. Lin, Current Concepts and Update for Sublingual Immunotherapy, Current Otorhinolaryngology Reports, 2013, 1, 2, 99

    CrossRef

  46. 46
    Yohalakshmi Chelladurai, Catalina Suarez-Cuervo, Nkiruka Erekosima, Julia M. Kim, Murugappan Ramanathan, Jodi B. Segal, Sandra Y. Lin, Effectiveness of Subcutaneous Versus Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma: A Systematic Review, The Journal of Allergy and Clinical Immunology: In Practice, 2013, 1, 4, 361

    CrossRef

  47. 47
    C. Mailhol, A. Didier, Immunothérapie allergénique dans le traitement de l’allergie aux pollens, Revue des Maladies Respiratoires, 2013, 30, 2, 142

    CrossRef

  48. 48
    Michael Katotomichelakis, Efthimios Simopoulos, Gregory Tripsianis, Emmanuel Prokopakis, Gerasimos Danielides, Stelios George Velegrakis, Miltos Livaditis, Vassilios Danielides, Improvement of olfactory function for quality of life recovery, The Laryngoscope, 2013, 123, 11
  49. 49
    Christine L. Segboer, Cornelis M. van Drunen, Ingrid Terreehorst, Carmen Rondon, Peter W. Hellings, Wytske J. Fokkens, New Findings in Nonallergic Rhinitis and Local Allergic Rhinitis, Current Otorhinolaryngology Reports, 2013, 1, 2, 106

    CrossRef

  50. You have free access to this content50
    G. Roberts, M. Xatzipsalti, L. M. Borrego, A. Custovic, S. Halken, P. W. Hellings, N. G. Papadopoulos, G. Rotiroti, G. Scadding, F. Timmermans, E. Valovirta, Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology, Allergy, 2013, 68, 9
  51. 51
    Désirée Larenas-Linnemann, Michael Blaiss, Hugo P. Van Bever, Enrico Compalati, Carlos E. Baena-Cagnani, Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012, Annals of Allergy, Asthma & Immunology, 2013, 110, 6, 402

    CrossRef

  52. 52
    V. Vovolis, L. Kalogiros, D. Mitsias, E. Sifnaios, Severe repeated anaphylactic reactions to sublingual immunotherapy, Allergologia et Immunopathologia, 2013, 41, 4, 279

    CrossRef

  53. 53
    Adrienne M. Laury, Rodney J. Schlosser, Sarah K. Wise, Sublingual immunotherapy and quality of life, Current Opinion in Otolaryngology & Head and Neck Surgery, 2013, 21, 3, 252

    CrossRef

  54. 54
    Giovanna Vitaliti, Piero Pavone, Francesco Guglielmo, Raffaele Falsaperla, Sublingual immunotherapy in preschool children: an update, Expert Review of Clinical Immunology, 2013, 9, 4, 385

    CrossRef

  55. You have free access to this content55
    P. A. Eigenmann, M. Atanaskovic-Markovic, J. O'B Hourihane, G. Lack, S. Lau, P. M. Matricardi, A. Muraro, L. Namazova Baranova, A. Nieto, N. G. Papadopoulos, L. A. Réthy, G. Roberts, O. Rudzeviciene, U. Wahn, M. Wickman, A. Høst, Testing children for allergies: why, how, who and when, Pediatric Allergy and Immunology, 2013, 24, 2
  56. 56
    Philippe Moingeon, Update on Immune Mechanisms Associated with Sublingual Immunotherapy: Practical Implications for the Clinician, The Journal of Allergy and Clinical Immunology: In Practice, 2013, 1, 3, 228

    CrossRef

  57. 57
    D. Lair, S. Vrtala, A. Magnan, Utilisation des peptides dans l’immunothérapie spécifique : actualités et perspectives, Revue Française d'Allergologie, 2013, 53, 7, 591

    CrossRef

  58. 58
    Carlos E. Baena-Cagnani, Désirée Larenas-Linnemann, Alvaro Teijeiro, Giorgio Walter Canonica, Giovanni Passalacqua, Will Sublingual Immunotherapy Offer Benefit for Asthma?, Current Allergy and Asthma Reports, 2013, 13, 6, 571

    CrossRef

  59. 59
    Antonio Cappella, Stephen Durham, Allergen immunotherapy for allergic respiratory diseases, Human Vaccines & Immunotherapeutics, 2012, 8, 10, 1499

    CrossRef

  60. 60
    M. Bonvalet, H. Moussu, E. Wambre, C. Ricarte, S. Horiot, A.-C. Rimaniol, W. W. Kwok, F. Horak, O. Beaumont, V. Baron-Bodo, P. Moingeon, Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy, Clinical & Experimental Allergy, 2012, 42, 12
  61. 61
    R. Valenta, R. Campana, K. Marth, M. van Hage, Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches, Journal of Internal Medicine, 2012, 272, 2
  62. 62
    Gitte Lund, Nicholas Willumsen, Jens Holm, Lars Harder Christensen, Peter Adler Würtzen, Kaare Lund, Antibody repertoire complexity and effector cell biology determined by assays for IgE-mediated basophil and T-cell activation, Journal of Immunological Methods, 2012, 383, 1-2, 4

    CrossRef

  63. 63
    F. Lavaud, J.-M. Perotin, G. Dutau, Chien, cheval, rongeurs : peut-on encore désensibiliser à ces animaux ?, Revue Française d'Allergologie, 2012, 52, 7, 484

    CrossRef

  64. 64
    Ulrich Wahn, Ludger Klimek, Anna Ploszczuk, Thomas Adelt, Bernhard Sandner, Ewa Trebas-Pietras, Peter Eberle, Albrecht Bufe, High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: A double-blind, placebo-controlled study, Journal of Allergy and Clinical Immunology, 2012, 130, 4, 886

    CrossRef

  65. 65
    Jochen Sieber, Mark Neis, Randolf Brehler, Regina Fölster-Holst, Alexander Kapp, Ludger Klimek, Hans Merk, Increasing long-term safety of seasonal grass pollen sublingual immunotherapy: the ECRIT study, Expert Opinion on Drug Safety, 2012, 11, 1, 7

    CrossRef

  66. 66
    Kim A. Woodrow, Kaila M. Bennett, David D. Lo, Mucosal Vaccine Design and Delivery, Annual Review of Biomedical Engineering, 2012, 14, 1, 17

    CrossRef

  67. 67
    Wen-Jiang Ma, Meng-Jing Bao, Jian-Ping Zhu, Hong-Yi Yao, Yi-Cheng Xie, Yan Guan, Fen-Fen Li, Xin-Wei Dong, Ying-Ming Zheng, Qiang-Min Xie, Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice, Vaccine, 2012, 30, 8, 1437

    CrossRef

  68. You have free access to this content68
    M. A. Calderon, R. Gerth van Wijk, I. Eichler, P. M. Matricardi, E. M. Varga, M. V. Kopp, P. Eng, B. Niggemann, A. Nieto, E. Valovirta, P. A. Eigenmann, G. Pajno, A. Bufe, S. Halken, K. Beyer, U. Wahn, Perspectives on allergen-specific immunotherapy in childhood: An EAACI position statement, Pediatric Allergy and Immunology, 2012, 23, 4
  69. 69
    Stella Lee, Summit Kundaria, Berrylin J. Ferguson, Practical clinical management strategies for the allergic patient with chronic rhinosinusitis, Current Opinion in Otolaryngology & Head and Neck Surgery, 2012, 20, 3, 179

    CrossRef

  70. 70
    Claire Mailhol, Alain Didier, Specific immunotherapy in grass pollen allergy, Human Vaccines & Immunotherapeutics, 2012, 8, 10, 1544

    CrossRef

  71. 71
    M.A. Calderón, P. Rodriguez del Rio, P. Demoly, Sublingual allergen immunotherapy in children: An evidence-based overview, Revue Française d'Allergologie, 2012, 52, 1, 20

    CrossRef

  72. 72
    M. A. Calderón, F. E. R. Simons, H.-J. Malling, R. F. Lockey, P. Moingeon, P. Demoly, Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile, Allergy, 2012, 67, 3
  73. 73
    Takashi Fujimura, Yoshitaka Okamoto, Masaru Taniguchi, Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review, Journal of Allergy, 2012, 2012, 1

    CrossRef

  74. 74
    Hugo P. S. Van Bever, Bee Wah Lee, Lynette Shek, Viewpoint: The future of research in pediatric allergy: What should the focus be?, Pediatric Allergy and Immunology, 2012, 23, 1
  75. 75
    T. Bieber, H.-U. Simon, Allergen-specific immunotherapy: current concepts and future directions, Allergy, 2011, 66, 6
  76. 76
    Tania Mucci, Satish Govindaraj, Jody Tversky, Allergic Rhinitis, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, 78, 5
  77. 77
    Jeffrey R Stokes, Thomas B Casale, Allergic rhinitis and asthma: celebrating 100 years of immunotherapy, Current Opinion in Immunology, 2011, 23, 6, 808

    CrossRef

  78. 78
    H. Ott, A. Bufe, H.F. Merk, Indikationen und Studienlage zur spezifischen Immuntherapie im Kindes- und Jugendalter, Der Hautarzt, 2011, 62, 9, 671

    CrossRef

  79. 79
    Jean-Pierre Allam, Natalija Novak, Local immunological mechanisms of sublingual immunotherapy, Current Opinion in Allergy and Clinical Immunology, 2011, 11, 6, 571

    CrossRef

  80. 80
    Karen J Mackenzie, Stephen M Anderton, Jürgen Schwarze, Peptide immunotherapy for childhood allergy - addressing translational challenges, Clinical and Translational Allergy, 2011, 1, 1, 13

    CrossRef

  81. 81
    Alfredo Iglesias-Cadarso, Pilar Hernández-Weigand, Risk factors for systemic reactions to allergen immunotherapy, Current Opinion in Allergy and Clinical Immunology, 2011, 11, 6, 579

    CrossRef

  82. 82
    Yi-Ling Ye, Ya-Hui Chuang, Bor-Luen Chiang, Strategies of mucosal immunotherapy for allergic diseases, Cellular and Molecular Immunology, 2011, 8, 6, 453

    CrossRef

  83. 83
    Doo Hee Han, Chae-Seo Rhee, Sublingual immunotherapy in allergic rhinitis, Asia Pacific Allergy, 2011, 1, 3, 123

    CrossRef

  84. 84
    Robert J Boyle, Mariam Elremeli, Juliet Hockenhull, Mary Gemma Cherry, Max K Bulsara, Michael Daniels, J.N.G. Oude Elberink, Venom immunotherapy for preventing allergic reactions to insect stings, The Cochrane Library,